Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jesia, H"'
Autor:
Garweg, J.G., Jana, ?., Carel, H., Tobias, N., Thomas, S., Sergio, L., Sobha, S., Ursula, S., Andreas, W., Fareed, A., David, C., John, D., Michel, G., Jesia, H., Jaroslava, D., Jan, H., Laurent, K., Eric, S., Claudia, D., Karl-Heinz, E., Nicolas, F., Frank, H., Frank, K., Dirk, S., Walter, S., Agnes, K., Andras, P., Andras, S., Attila, V., Balazs, V., Francesco, B., Chiara, E., Edoardo, M., Massimo, N., Enrico, P., Federico, R., Viola, F., Gianni, V., Vilma-Jurate, B., Andrius, C., Ewa, G., Andrzej, G., Jakub, K., Zofia, M., Dorota, R., Marek, R., Bozena, R., Slawomir, T., Tomasz, Z., Miguel, A., Jo??o Castro Sousa, Manuel, F., Jo??o Pereira Figueira, Sara, V., Mikulas, A., Monika, G., Gabriela, P., Katarina, S., Alfredo, A., Lluis Arias Barquet, Anniken, B., Carlos Cava Valenciano, Enrique, C., Laura, S., Justus, G., Ioannis, P., Andrew, L., Martin, M., Deepali, V.
Publikováno v:
Garweg, Justus G; Štefanickova, Jana; Hoyng, Carel; Niesen, Tobias; Schmelter, Thomas; Leal, Sergio; Sivaprasad, Sobha (2022). Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial. Advances in therapy, 39(6), pp. 2701-2716. Springer 10.1007/s12325-022-02119-z
INTRODUCTION The purpose was to compare two flexible regimens of intravitreal aflibercept (IVT-AFL) with fixed dosing every 8 weeks, beyond the first year of treatment, in patients with diabetic macular edema (DME). VIOLET was a 100-week, randomized,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcbec03ce9fc285fb4715f58e7bf95e6
https://doi.org/10.1007/s12325-022-02119-z
https://doi.org/10.1007/s12325-022-02119-z
Autor:
Garweg, Jg, Stefanickova, J, Hoyng, C, Schmelter, T, Niesen, T, Sowade, O, Sivaprasad, S, Adan, A, Alexik, M, Ali, F, Amaro, M, Balciuniene, V, Bandello, Fm, Arias Barquet, L, Beck, A, Bell, K, Boscia, F, Bures, A, Carneiro, A, Chow, Dr, Cimbalas, A, Dahlke, C, Deepali, V, Dickinson, Jd, Dollin, M, Eandi, C, Emmerich, K, Feltgen, N, Pereira Figueira, J, Findl, O, Gajdosova, M, Gale, Rp, John Galic, I, Garweg, J, Gasser-Steiner, V, Giunta, M, Gonder, Jr, Grzybowski, A, Hamouz, J, Hattenbach, L, Holz, Fg, Jesia, H, Kaluzny, J, Kerenyi, A, Kertes, Pj, Koch, F, Kodjikan, L, Lederer, De, Liehneova, I, Lorenz, K, Lotery, Aj, Mckibbin, M, Menon, Gv, Michalewska, Z, Midena, E, Nicolo, M, Papp, A, Pavlovicova, G, Peiretti, E, Vaz-Pereira, S, Perri, P, Petropoulos, I, Queguiner, F, Raczynska, K, Sararols-Ramsay, L, Rekas, M, Ricci, F, Romanowska-Dixon, B, Sachs, Hg, Mohand-Said, S, Sandner, D, Schmidt-Erfurth, U, Sekundo, W, Seres, A, Souied, E, Castro de Sousa, J, Stankiewicz, A, Struharova, K, Studnicka, J, Cervera Taulet, E, Taylor, S, Teper, S, Vajas, A, Cava Valenciano, C, Varsanyi, B, Viola, F, Virgili, G, Wagenfeld, L, Walters, G, Wiedemann, P, Zarnowski, T
Purpose: To examine vision-related quality of life in patients with diabetic macular edema (DME) treated with intravitreal aflibercept (EYLEA, Regeneron Pharmaceuticals, Inc, Tarrytown, NY). Design: AQUA was a multicenter, open-label, single-arm, pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::11a401a9bb009904e1d904a0afe1d8d3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.